TY - JOUR
T1 - Similar 5-Year Estimated Glomerular Filtration Rate Between Kidney Transplants From Uncontrolled and Controlled Donors After Circulatory Death-A Dutch Cohort Study
AU - Peters-Sengers, Hessel
AU - van der Heide, Jaap J. Homan
AU - Heemskerk, Martin B. A.
AU - ten Berge, Ineke J. M.
AU - Ultee, Fred C. W.
AU - Idu, Mirza M.
AU - Betjes, Michiel G. H.
AU - van Zuilen, Arjan D.
AU - Christiaans, Maarten H. L.
AU - Hilbrands, Luuk H.
AU - de Vries, Aiko P. J.
AU - Nurmohamed, Azam S.
AU - Berger, Stefan P.
AU - Bemelman, Frederike J.
PY - 2017/6
Y1 - 2017/6
N2 - Background. Organ shortage persists despite a high rate of donation after circulatory death (DCD) in the Netherlands. The median waiting time for a deceased donor kidney in 2013 was 3.5 years. Most DCD kidneys are from controlled DCD (cDCD; Maastricht category III). Experience with uncontrolled donors after cardiac death (uDCD), that is, donors with an unexpected and irreversible cardiac arrest (Maastricht categories I and II), is increasing; and its effect on transplant outcomes needs evaluation. Methods. We used the Dutch Organ Transplantation Registry to include recipients (>= 18 years old) from all Dutch centers who received transplants from 2002 to 2012 with a first DCD kidney. We compared transplant outcome in uDCD (n = 97) and cDCD (n = 1441). Results. Primary nonfunction in uDCD was higher than in the cDCD (19.6% vs 9.6%, P <0.001, respectively). Delayed graft function was also higher in uDCD than in cDCD, but not significantly (73.7% vs 63.3%, P = .074, respectively). If censored for primary nonfunction, estimated glomerular filtration rates after 1 year and 5 years were comparable between uDCD and cDCD (1 year: uDCD, 44.3 (23.4) mL/min/m(2) and cDCD, 45.8 (24.1) mL/min/m(2); P = 0.621; 5 years: uDCD, 49.1 (25.6) mL/min/m(2) and cDCD, 47.7 (21.7) mL/min/m(2); P = 0.686). The differences in primary nonfunction between kidneys from uDCD and cDCD were explained by differences in the first warm ischemic period, cold ischemic time, and donor age. Conclusions. We conclude that uDCD kidneys have potential for excellent function and can constitute a valuable extension of the donor pool. However, further efforts are necessary to address the high rate of primary nonfunction.
AB - Background. Organ shortage persists despite a high rate of donation after circulatory death (DCD) in the Netherlands. The median waiting time for a deceased donor kidney in 2013 was 3.5 years. Most DCD kidneys are from controlled DCD (cDCD; Maastricht category III). Experience with uncontrolled donors after cardiac death (uDCD), that is, donors with an unexpected and irreversible cardiac arrest (Maastricht categories I and II), is increasing; and its effect on transplant outcomes needs evaluation. Methods. We used the Dutch Organ Transplantation Registry to include recipients (>= 18 years old) from all Dutch centers who received transplants from 2002 to 2012 with a first DCD kidney. We compared transplant outcome in uDCD (n = 97) and cDCD (n = 1441). Results. Primary nonfunction in uDCD was higher than in the cDCD (19.6% vs 9.6%, P <0.001, respectively). Delayed graft function was also higher in uDCD than in cDCD, but not significantly (73.7% vs 63.3%, P = .074, respectively). If censored for primary nonfunction, estimated glomerular filtration rates after 1 year and 5 years were comparable between uDCD and cDCD (1 year: uDCD, 44.3 (23.4) mL/min/m(2) and cDCD, 45.8 (24.1) mL/min/m(2); P = 0.621; 5 years: uDCD, 49.1 (25.6) mL/min/m(2) and cDCD, 47.7 (21.7) mL/min/m(2); P = 0.686). The differences in primary nonfunction between kidneys from uDCD and cDCD were explained by differences in the first warm ischemic period, cold ischemic time, and donor age. Conclusions. We conclude that uDCD kidneys have potential for excellent function and can constitute a valuable extension of the donor pool. However, further efforts are necessary to address the high rate of primary nonfunction.
KW - HEART-BEATING DONORS
KW - CARDIAC DEATH
KW - ORGAN DONATION
KW - COLD-STORAGE
KW - ARREST
KW - POOL
U2 - 10.1097/TP.0000000000001211
DO - 10.1097/TP.0000000000001211
M3 - Article
C2 - 27257998
SN - 0041-1337
VL - 101
SP - 1144
EP - 1151
JO - Transplantation
JF - Transplantation
IS - 6
ER -